Home > News > Nanobiotechnology Under Pressure to Justify Funding it has Received
August 30th, 2005
Nanobiotechnology Under Pressure to Justify Funding it has Received
Abstract:
Nanotechnology has received as much media attention (as) any other science sector since the space race of the 1960s. This hype has attracted large sums of 'reactionary' public and venture capital funding, and has brought in its wake tremendous pressure on market participants to deliver results.
The onus is now on participants in the nanobiotechnology applications sector to incorporate extensively researched technologies into commercially viable products.
Source:
prnewswire
Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over 14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||